BR112023022649A2 - Uso de 5-nitro-8-hidroxiquinolina - Google Patents
Uso de 5-nitro-8-hidroxiquinolinaInfo
- Publication number
- BR112023022649A2 BR112023022649A2 BR112023022649A BR112023022649A BR112023022649A2 BR 112023022649 A2 BR112023022649 A2 BR 112023022649A2 BR 112023022649 A BR112023022649 A BR 112023022649A BR 112023022649 A BR112023022649 A BR 112023022649A BR 112023022649 A2 BR112023022649 A2 BR 112023022649A2
- Authority
- BR
- Brazil
- Prior art keywords
- hydroxyquinoline
- nitro
- prodrug
- solvate
- pharmaceutically acceptable
- Prior art date
Links
- RJIWZDNTCBHXAL-UHFFFAOYSA-N nitroxoline Chemical compound C1=CN=C2C(O)=CC=C([N+]([O-])=O)C2=C1 RJIWZDNTCBHXAL-UHFFFAOYSA-N 0.000 title abstract 5
- 239000000651 prodrug Substances 0.000 abstract 2
- 229940002612 prodrug Drugs 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
uso de 5-nitro-8-hidroxiquinolina. é fornecido o uso de 5-nitro-8-hidroxiquinolina. é especificamente fornecido o uso de 5-nitro-8- hidroxiquinolina, um sal farmaceuticamente aceitável do mesmo, uma forma cristalina do mesmo, um solvato do mesmo, um derivado de isótopo do mesmo ou um pró-fármaco do mesmo na preparação de um medicamento antiviral. a 5-nitro-8- hidroxiquinolina, o sal farmaceuticamente aceitável do mesmo, a forma cristalina do mesmo, o solvato do mesmo, o derivado de isótopo do mesmo ou o pró-fármaco do mesmo possuem atividade significativa no combate ao papilovírus humano.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110601777 | 2021-05-31 | ||
| PCT/CN2022/095861 WO2022253159A1 (zh) | 2021-05-31 | 2022-05-30 | 5-硝基-8-羟基喹啉的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023022649A2 true BR112023022649A2 (pt) | 2024-01-16 |
Family
ID=84322805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023022649A BR112023022649A2 (pt) | 2021-05-31 | 2022-05-30 | Uso de 5-nitro-8-hidroxiquinolina |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4349335A1 (pt) |
| KR (1) | KR20240016311A (pt) |
| CN (1) | CN116940360A (pt) |
| AU (1) | AU2022284147A1 (pt) |
| BR (1) | BR112023022649A2 (pt) |
| CA (1) | CA3219273A1 (pt) |
| WO (1) | WO2022253159A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115433126B (zh) * | 2022-08-12 | 2023-10-20 | 浙江工业大学 | 一种功能化喹啉类比色离子探针及其合成方法与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103588660B (zh) * | 2013-11-18 | 2016-06-01 | 中国医学科学院生物医学工程研究所 | 一种新型的酰基苯胺化合物及用途 |
| US20210363165A1 (en) | 2018-09-29 | 2021-11-25 | Jiangsu Yahong Meditech Co., Ltd. | Nitroxoline prodrug and use thereof |
| CN112402388A (zh) * | 2019-08-05 | 2021-02-26 | 江苏亚虹医药科技股份有限公司 | 一种用于治疗膀胱癌的口服固体制剂及其制备方法 |
| CN111514142B (zh) | 2020-05-29 | 2021-04-06 | 江苏亚虹医药科技股份有限公司 | 含硝羟喹啉前药的药物组合物及其制备方法和应用 |
| CN111773193A (zh) * | 2020-07-03 | 2020-10-16 | 江苏亚虹医药科技有限公司 | 含硝羟喹啉赖氨酸盐的药物组合物及其制备方法和用途 |
-
2022
- 2022-05-30 WO PCT/CN2022/095861 patent/WO2022253159A1/zh active Application Filing
- 2022-05-30 AU AU2022284147A patent/AU2022284147A1/en active Pending
- 2022-05-30 KR KR1020237044054A patent/KR20240016311A/ko unknown
- 2022-05-30 BR BR112023022649A patent/BR112023022649A2/pt unknown
- 2022-05-30 CA CA3219273A patent/CA3219273A1/en active Pending
- 2022-05-30 CN CN202280018341.4A patent/CN116940360A/zh active Pending
- 2022-05-30 EP EP22815205.4A patent/EP4349335A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022284147A1 (en) | 2024-01-18 |
| CN116940360A (zh) | 2023-10-24 |
| CA3219273A1 (en) | 2022-12-08 |
| WO2022253159A1 (zh) | 2022-12-08 |
| EP4349335A1 (en) | 2024-04-10 |
| KR20240016311A (ko) | 2024-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015023412A8 (pt) | 3-pirimidin-4-il-oxazolidin-2-onas como inibidores de idh mutante, sua composição farmacêutica e seu uso. | |
| BR112015029918A2 (pt) | uso de alta dose de pridopidina para tratar a doença de huntington | |
| BR112016003229A8 (pt) | composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica | |
| BR112022003514A2 (pt) | Degradadores bifuncionais de brd9 e seus métodos de uso | |
| CR20160205A (es) | Inhibidores de kras g12c | |
| BR112015029512A8 (pt) | derivados de pirazolopirrolidina, seus usos, e composição e combinação farmacêuticas | |
| NO20074619L (no) | Spiro-oksindolforbindelser og deres anvendelse som medikamenter | |
| HRP20202051T1 (hr) | Aril supstituirani pirimidini za uporabu kod infekcije virusom influence | |
| BR112016008016A2 (pt) | inibidores de kras g12c | |
| UY29085A1 (es) | Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes | |
| AR062392A1 (es) | Uso de compuestos y derivados de 2,5 dihidroxibenceno para el tratamiento de rosacea | |
| BR112015029401A8 (pt) | derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas | |
| AR107828A1 (es) | 2-amino-n-[7-metoxi-2,3-dihidroimidazo-[1,2-c]quinazolin-5-il]pirimidin-5-carboxamidas como inhibidor de pi3k | |
| BR112016002651A2 (pt) | composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, combinação, formulação farmacêutica, métodos para exterminar uma micobactéria e/ou inibir a replicação das micobactérias, e para tratar uma infecção e uma doença, e, uso de um composto | |
| BR112019003197A2 (pt) | compostos contendo espirocíclicos e seus usos farmacêuticos | |
| BR112022001568A2 (pt) | Composto, método para preparação do composto, composição farmacêutica, e, uso do composto | |
| NZ700924A (en) | Dosage regimen for a pi-3 kinase inhibitor | |
| BR112017020081A2 (pt) | análogos deuterados de etifoxina, seus derivados e usos dos mesmos | |
| BR112017006272A2 (pt) | composição farmacêutica para tratar colite ulcerativa. | |
| AR062393A1 (es) | Uso de derivado del 2.5-dihidrixibenceno para el tratamiento de artritis y dolor | |
| BR112023022649A2 (pt) | Uso de 5-nitro-8-hidroxiquinolina | |
| BR112019002513A2 (pt) | uso e dosagem de agentes terapêuticos para endometriose | |
| PH12021550218A1 (en) | Use of riluzole oral disintigrating tablets for treating diseases | |
| AR062401A1 (es) | Uso de derivados del 2,5-dihidroxibenceno para tratar dermatitis | |
| PH12020551911A1 (en) | Use of riluzole oral disintigrating tablets for treating diseases |